China Life posts strong first half, proposes dividend, amends articles

China Life Insurance Company Limited reported a 6.9% year-on-year increase in net profit attributable to equity holders, reaching 40,931 million yuan for the six months ended June 30, 2025. Gross written premiums hit a record high of 525,088 million yuan, up 7.3%. The company also saw its total assets exceed 7 trillion yuan, reaching 7,292,355 million yuan, an increase of 7.8% from the end of 2024. The board of directors proposed an interim cash dividend of 0.238 yuan per share (inclusive of tax), totaling approximately 6,727 million yuan, for shareholders’ approval on September 25, 2025, with payment scheduled for November 18, 2025.

Alongside its financial performance, the company disclosed amendments to its articles of association, subject to shareholder and regulatory approval. These changes aim to enhance corporate governance by clarifying shareholder rights and obligations, refining the board and management structure, and updating provisions related to share issuance, repurchase, and financial reporting. The amendments also address compliance with new regulatory standards, including revised requirements for independent directors and the establishment of special committees, ensuring the company's continued alignment with evolving financial regulations.

The company's solvency ratios remained strong, with a comprehensive solvency ratio of 190.94% and a core solvency ratio of 139.54% at June 30, 2025, despite a slight decrease from the end of 2024 due to increased equity asset allocation and market interest rate fluctuations. China Life maintained its AAA Integrated Risk Rating for the fourth quarter of 2024 and the first quarter of 2025, reflecting its robust risk management capabilities.